PWS
FUSN

Paragon Wealth Strategies’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Paragon Wealth Strategies’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30
Closed – – 281
2022
Q3 		$0 Buy
+30
New +$75 ﹤0.01% 192
2021
Q3 		– Sell
-18
Closed – – 286
2021
Q2 		$0 Buy
+18
New +$155 ﹤0.01% 296

Other funds holding FUSN

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Paragon Wealth Strategies's FUSN Position: Q4 2022 in Review

Paragon Wealth Strategies sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q4 2022, closing a stake of 30 shares.

Paragon Wealth Strategies first reported a position in FUSN in Q2 2021 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 30 funds tracked by Wall St. Rank hold FUSN as of Q4 2022.

  • Paragon Wealth Strategies reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q4 2022 after selling out during the quarter.
  • Paragon Wealth Strategies sold 30 Fusion Pharmaceuticals Inc. Common Shares shares in Q4 2022.
  • Paragon Wealth Strategies first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2021 and held it in 2 quarters.
  • Paragon Wealth Strategies's Fusion Pharmaceuticals Inc. Common Shares position peaked at $0 in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q4 2022.

Based on Paragon Wealth Strategies's 13F filing for Q4 2022, filed 30 Jan 2023.